Addition of triglycerides with arachidonic acid or docosahexaenoic acid to infant formula has tissue- and lipid class-specific effects on fatty acids and hepatic desaturase activities in formula-fed piglets

Addition of triglycerides with arachidonic acid or docosahexaenoic acid to infant formula has tissue- and lipid class-specific effects on fatty acids and hepatic desaturase activities in formula-fed piglets
复制标题

DOI:
10.1093/jn/128.8.1376
复制
发表时间:
1998-08-01
影响因子:
4.2
通讯作者:
Rioux, FM
Rioux, FM
中科院分区:
医学2区
文献类型:
--
作者:
de la Presa-Owens, S;Innis, SM;Rioux, FM

文献摘要

被引文献

相似文献

研究配方中添加甘油三酯与花生四烯酸[20:4(n-6)]或二十二碳六烯酸[22:6(n-3)]对乳糜粒、低密度脂蛋白、高密度脂蛋白、肝、心、肾、脑(n-6)和(n-3)脂肪酸的影响。仔猪从出生到18日龄,分别饲喂20%18:2(n-6)和2%18:3(n-3)配方,不添加或不添加0.8%20:4(n-6)或0.3%22:6(n-3)。在配方中添加20:4(n-6)或22:6(n-3)的效果因组织和脂肪的不同而不同,大脑表现出对变化的抵抗力,20:4(n-6)配方饲喂的仔猪血浆、心脏和肾脏磷脂和甘油三酯显著高于对照组。肝脏甘油三酯20:4(n-6),但血浆和组织磷脂18:2(n-6)低于不饲喂20:4(n-6)配方的仔猪。相反,补充22:6(n-3)对血浆或组织18:2(n-6)没有影响。与不饲喂22:6(n-3)相比,饲喂22:6(n-3)配方的仔猪肝脏磷脂(高30-92%)和甘油三酯(高200%)的含量较高,同时肝脏磷脂酰乙醇胺(平均+/-扫描电子显微镜,分别为8.6+/-0.4和10.5+/-0.4%)的含量较低,但甘油三酯(5.2+/-0.4和11.5+/-0.5%)的含量较高。较高的肝、心、肾磷脂含量为20:5(n-3)。这些结果表明,饲料20:4(n-6)和组织18:2(n-6)之间以及饲料20:4(n-6)和组织20:5(n-3)之间存在竞争性相互作用,而不是22:6(n-3)。结果还表明,即使在低摄入量的情况下,补充22:6(n-3)或20:4(n-6)也会改变组织磷脂20:4(n-6)至20:5(n-3)的平衡。研究日粮中添加20:4(n-6)和22:6(n-3)的生理效应时,应考虑不同组织对饲料脂肪酸的不同敏感性。
The effects of including triglycerides with arachidonic [20:4(n-6)] or docosahexaenoic acid [22:6(n-3)] in formula on plasma chylomicron, LDL and HDL, liver, heart, kidney and brain (n-6) and (n-3) fatty acids were investigated in formula-fed piglets. Piglets were fed formula with (in % total fatty acids) 20% 18:2(n-6) and 2% 18:3(n-3) without or with 0.8% 20:4(n-6) or 0.3% 22:6(n-3) from birth to 18 d. The effects of adding 20:4(n-6) or 22:6(n-3) to the formula differed among different tissues and lipids, with the brain showing resistance to change, Piglets fed formula with 20:4(n-6) had significantly higher plasma, heart and kidney phospholipid and triglyceride, and liver triglyceride 20:4(n-6), but lower plasma and tissue phospholipid 18:2(n-6) than piglets fed formula without 20:4(n-6). Supplementation with 22:6(n-3), in contrast, had no effect on plasma or tissue 18:2(n-6). Higher 22:6(n-3) in liver phospholipid (30-92% greater) and triglyceride (200% greater) in piglets fed formula with 22:6(n-3) rather than without 22:6(n-3) was accompanied by lower 20:4(n-6) in liver phosphatidylethanolamine (mean +/- SEM, 8.6 +/- 0.4 and 10.5 +/- 0.4% fatty acids, respectively), but higher 20:4(n-6) in triglyceride (5.2 +/- 0.4 and 11.5 +/- 0.5%, respectively), and higher liver, heart and kidney phospholipid 20:5(n-3). These results indicate competitive interaction between dietary 20:4(n-6) and tissue 18:2(n-6), and between dietary 20:4(n-6) and tissue 20:5(n-3), rather than 22:6(n-3). The results also show that even at low intakes, dietary 22:6(n-3) or 20:4(n-6) supplementation alters the tissue phospholipid 20:4(n-6) to 20:5(n-3) balance. Studies on the physiologic effects of dietary 20:4(n-6) and 22:6(n-3) supplementation should consider the different sensitivity among tissues to dietary fatty acids.